Hcl Daisource

Tissue and Cell Extraction and Purification
EP10011 100 Tests
EUR 763.2

Diasource Laboratories manufactures the hcl daisource reagents distributed by Genprice. The Hcl Daisource reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Diasource. Other Hcl products are available in stock. Specificity: Hcl Category: Daisource

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

True north Cryobox 1.5/2.0mLBlue
PK10
EUR 100.8

True north Cryobox 1.5/2.0mLBlue
PK10
EUR 162

True north Cryobox 1.5/2mLPurple
PK10
EUR 162

Dog True insulin ELISA kit
192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog True insulin ELISA kit
1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Test Assays information

ML133 HCl
B2199-5 5 mg
EUR 129.6
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.

ML133 HCl
B2199-50 50 mg
EUR 420
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.

ML133 HCl
B2199-S Evaluation Sample
EUR 97.2
Description: ML133 is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 ?M (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.

GW3965 HCl
A8444-10 10 mg
EUR 205.2
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types.

GW3965 HCl
A8444-5 5 mg
EUR 154.8
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types.

GW3965 HCl
A8444-5.1 10 mM (in 1mL DMSO)
EUR 199.2
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types.

GW3965 HCl
A8444-50 50 mg
EUR 614.4
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types.

LX7101 HCL
B5863-10 10 mg
EUR 927.6
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments.

LX7101 HCL
B5863-100 100 mg
EUR 4837.2
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments.

LX7101 HCL
B5863-5 5 mg
EUR 582
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments.

LX7101 HCL
B5863-5.1 10 mM (in 1mL DMSO)
EUR 576
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments.

LX7101 HCL
B5863-50 50 mg
EUR 3099.6
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments.

ADL5859 HCl
A2986-100 100 mg
EUR 1423.2
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening.

ADL5859 HCl
A2986-25 25 mg
EUR 588
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening.

ADL5859 HCl
A2986-5 5 mg
EUR 226.8
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening.

ADL5859 HCl
A2986-5.1 10 mM (in 1mL DMSO)
EUR 261.6
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening.

SRT1720 HCl
A4180-10 10 mg
EUR 309.6
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol.